Rafferty Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Sell |
81,096
-7,716
| -9% | -$281K | 0.01% | 505 |
|
|
2025
Q1 | $3.22M | Sell |
88,812
-12,481
| -12% | -$452K | 0.01% | 464 |
|
|
2024
Q4 | $4.26M | Buy |
101,293
+2,892
| +3% | +$122K | 0.02% | 446 |
|
|
2024
Q3 | $5.47M | Sell |
98,401
-27,758
| -22% | -$1.54M | 0.02% | 403 |
|
|
2024
Q2 | $5.19M | Sell |
126,159
-55,325
| -30% | -$2.27M | 0.02% | 407 |
|
|
2024
Q1 | $8.47M | Sell |
181,484
-40,426
| -18% | -$1.89M | 0.03% | 333 |
|
|
2023
Q4 | $10.6M | Buy |
221,910
+38,859
| +21% | +$1.86M | 0.04% | 260 |
|
|
2023
Q3 | $6.53M | Buy |
183,051
+21,376
| +13% | +$762K | 0.04% | 334 |
|
|
2023
Q2 | $7.46M | Sell |
161,675
-13,900
| -8% | -$641K | 0.04% | 311 |
|
|
2023
Q1 | $7.04M | Sell |
175,575
-22,725
| -11% | -$911K | 0.05% | 292 |
|
|
2022
Q4 | $9.19M | Buy |
198,300
+57,610
| +41% | +$2.67M | 0.08% | 199 |
|
|
2022
Q3 | $5.83M | Buy |
140,690
+64,107
| +84% | +$2.65M | 0.06% | 302 |
|
|
2022
Q2 | $4.57M | Sell |
76,583
-5,154
| -6% | -$307K | 0.04% | 292 |
|
|
2022
Q1 | $5.94M | Buy |
81,737
+14,046
| +21% | +$1.02M | 0.04% | 336 |
|
|
2021
Q4 | $5.69M | Buy |
67,691
+37,052
| +121% | +$3.12M | 0.03% | 330 |
|
|
2021
Q3 | $2.76M | Buy |
30,639
+4,993
| +19% | +$450K | 0.02% | 527 |
|
|
2021
Q2 | $2.45M | Sell |
25,646
-599
| -2% | -$57.1K | 0.02% | 618 |
|
|
2021
Q1 | $2.99M | Buy |
26,245
+19,812
| +308% | +$2.26M | 0.02% | 500 |
|
|
2020
Q4 | $891K | Sell |
6,433
-20,440
| -76% | -$2.83M | 0.01% | 533 |
|
|
2020
Q3 | $2.21M | Buy |
26,873
+12,840
| +91% | +$1.06M | 0.03% | 382 |
|
|
2020
Q2 | $1.1M | Buy |
14,033
+7,335
| +110% | +$574K | 0.02% | 515 |
|
|
2020
Q1 | $298K | Sell |
6,698
-50,227
| -88% | -$2.23M | 0.01% | 439 |
|
|
2019
Q4 | $2.43M | Sell |
56,925
-41,882
| -42% | -$1.79M | 0.04% | 306 |
|
|
2019
Q3 | $4.23M | Buy |
98,807
+12,306
| +14% | +$526K | 0.07% | 174 |
|
|
2019
Q2 | $5.49M | Buy |
86,501
+21,478
| +33% | +$1.36M | 0.1% | 141 |
|
|
2019
Q1 | $4.51M | Buy |
+65,023
| New | +$4.51M | 0.07% | 155 |
|